BeStock  
Stocks › Biotechnology › CBIO

Crescent Biopharma CBIO

US equityMarket cap rank #3744Biotechnology
$13.49 −$0.08 (-0.59%)
Market closed · Oct 8, 7:00 am ET · Last extended-hours $13.49 0.00%
Open$13.47
Prev close$13.57
Day range$13.27 – $14.20
Volume1.05M
Market cap$501.07M
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts4
Average target$29.75+120.5% vs. price
  • Buy 100%
Low $27.00Now $13.49Avg $29.75High $36.00

Recent rating changes

The last 20 actions on file set price targets from $22.00 to $36.00, averaging $30.13.

DateFirmRatingTarget
6 Oct 2026 Stifel BUY $28.00
6 Oct 2026 H.C. Wainwright BUY $36.00
5 Oct 2026 LifeSci Capital BUY $28.00
14 Sep 2026 Wedbush BUY $27.00
31 Jul 2026 Stifel BUY $28.00
31 Jul 2026 H.C. Wainwright HOLD –
30 Jul 2026 LifeSci Capital BUY $28.00
16 Jul 2026 H.C. Wainwright HOLD –
23 Jun 2026 Piper Sandler BUY $35.00
23 Jun 2026 Stifel BUY $30.00
1 Jun 2026 Stifel BUY $30.00
1 Jun 2026 H.C. Wainwright HOLD –
26 May 2026 Piper Sandler BUY $35.00
4 May 2026 H.C. Wainwright BUY $22.00
30 Apr 2026 LifeSci Capital BUY $28.00
30 Apr 2026 Piper Sandler BUY $35.00
30 Apr 2026 Wedbush BUY $27.00
30 Apr 2026 Stifel BUY $30.00
29 Apr 2026 TD Cowen BUY –
29 Apr 2026 Guggenheim BUY $35.00

Discussion

No comments yet — be the first to weigh in on CBIO.

Leave a comment

Scroll to Top